TGTuğba Falay Gür

Tuğba Falay Gür

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tuğba Falay Gür has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and Mycological Profiles of Chronic and Recalcitrant Dermatophytosis: Türkiye, 2022–2024

    by Murat Durdu, Hazal Kandemir, Ayşe Sultan Karakoyun, Pavlína Lysková, Daniela Kolarczyková, Oğuzhan Bingöl, Yasemin Erdem, Funda Aktürk-Gözel, Özlem Su-Küçük, Melisa Özay, et al.

    This study investigated the treatment outcomes of 91 patients with chronic and recalcitrant dermatophytosis from 20 hospitals in Türkiye between June 2022 and March 2024, as well as the in vitro antifungal susceptibility and squalene epoxidase ( SQLE ) substitution profiles of the dermatophytes obtained from these patients. Molecular identification by sequencing 91 isolates, revealed 76 Trichophyton mentagrophytes ITS genotype VIII (TmVIII; also known as T . indotineae ) isolates, 13 Trichophyton rubrum , one Trichophyton tonsurans , and one Microsporum canis . The Phe397Leu substitution predominated in the SQLE , and Tyr414His co-occurred in nine TmVIII isolates. Five novel substitutions were observed in TmVIII. Among 13 T . rubrum isolates, three showed different SQLE substitution patterns compared to the wild-type strain. EUCAST antifungal susceptibility testing revealed high minimum inhibitory concentrations (MICs) for terbinafine (TRB) (> 0.25 mg/L) and for fluconazole (FLZ) (≥ 16 mg/L), indicating resistance in most TmVIII isolates. Of the 91 patients, 83 responded to FLZ, itraconazole (ITZ), TRB, or voriconazole-based regimens. While adjunct therapy with FLZ and resveratrol (RES) led to improvement in 28/29 patients despite their high in vitro inhibition concentrations, ITZ and curcumin (CUR) therapy was successful in 3/3 patients. However, the in vitro efficiency of CUR could not be evaluated. These findings highlight the local occurrence of specific SQLE substitutions, underscore the importance of EUCAST MIC testing combined with SQLE sequencing for surveillance, and support further evaluation of RES and CUR as an adjunct in TRB-resistant TmVIII.


  • Accommodation amplitude change after cosmetic use of the botulinum toxin in the upper face

    by Nur Demir, Hasine Gozde Dalkılıc, Tugba Falay Gur, Belma Kayhan, Sukru Sevincli, Burce Can Kuru, Murat Sonmez

    Cosmetic botulinum toxin A (BoNT-A) injections are increasing worldwide. Adverse effects need to be evaluated in more detail for BoNT-A regulations. This study aims to assess the anticholinergic effect of BoNT-A on accommodation amplitude (AA) after upper face application. Twenty patients aged between 20 and 45 years were recruited in this prospective, interventional study. Abobotulinum toxin A of 500 units was diluted with 3 ml saline and injected into the forehead, glabellar and periorbital area. AA was measured with both the push-up and minus-lens techniques before and after two weeks of the injections. T-test for normally distributed variables was applied for the comparison of the results. The study group comprised 18 women and 2 men with a mean age of 33.9 ± 8.59. AA decreased significantly after two weeks of the injection. In the push-up test, AA was 9.18 ± 4.72 D before BoNT-A injection and decreased to 7.11 ± 3.02 D after the injection (p < 0.001). In the minus lens test, AA reduced from 5.86 ± 2.24 D to 5.24 ± 2.06 D after BoNT-A injection (p < 0.001). Refraction did not change in any of the participants. The present study showed that cosmetic upper face BoNT-A injections reduced AA. However, this reduction did not result in any significant symptomatic effects in the patients. These findings suggest that while BoNT-A injection has a measurable impact on the ciliary muscle or its parasympathetic innervation, it may not lead to noticeable clinical outcomes.


  • Plasma matrix metalloproteinase‐9 level change with omalizumab treatment in chronic spontaneous urticaria

    by Tuğba Falay Gür, Sevil Savaş Erdoğan, Fatih Özçelik, Mehmet Salih Gürel, Bilal Doğan

    Background Matrix metalloproteinase-9 (MMP-9) is an enzyme that contributes to inflammation and tissue remodelling. In chronic urticaria, increased plasma levels of MMP-9 and its correlation with disease severity have been shown in several studies, suggesting that MMP-9 could be used to evaluate the effects of new treatments. We aimed to compare MMP-9 levels in chronic urticaria patients with those of healthy patients. Then we planned to investigate the changes in plasma MMP-9 levels with chronic urticaria treatment, the role of this enzyme in demonstrating the efficacy of treatment, and its correlation with C-reactive protein (CRP). Methods Forty-one patients with chronic urticaria who were scheduled for omalizumab treatment and 41 sex- and age-matched healthy volunteers were included in the study. In the patient group, before treatment and at the end of the 12th week, the urticaria activity score used for 7 consecutive days (UAS7) was calculated, and the MMP-9 and CRP levels were measured. Plasma MMP-9 levels were measured from venous blood in the control group. Results The plasma MMP-9 levels of the patients before treatment were significantly higher than those of the control group (P < 0.01). In the patient group, there was no significant relationship between the UAS7 score and the MMP-9 and CRP levels before treatment. The UAS7 values ​​were 28 ± 7 before omalizumab treatment and 5 ± 6 at the end of the 12th week (P < 0.0001). The post-treatment MMP-9 levels (1818 ± 297 pg/mL) were higher compared to the pre-treatment values (1617 ± 380) (P < 0.05). The post-treatment CRP levels of the patients (2.41 ± 2.17 mg/L) were lower than their pre-treatment CRP levels (8.20 ± 19.70) (P < 0.05). Conclusion MMP-9 levels were not associated with the severity of disease, and MMP-9 levels were not decreased with treatment response. Therefore, MMP-9 cannot be used as a parameter of disease activity in chronic urticaria or to evaluate the efficacy of new treatments.


  • Effect of video-based patient information on patients’ anxiety and pain levels before skin biopsy: a randomized controlled study

    by Sevil Savaş Erdoğan, Tuğba Falay Gür, Bilal Doğan

    Effective use of technology can provide advantages for both patients and physicians in skin biopsy practice. We aimed to investigate the effects of video-based information on the anxiety, pain and satisfaction levels of patients undergoing biopsy. Patients were randomized and divided into two groups as video-informed and verbally informed. The anxiety levels were evaluated using the State-Trait Anxiety Inventory (STAI) and measuring the physiological parameters, systolic and diastolic blood pressure, heart rate, and respiratory rate. After the informing process, the STAI’s state form was reevaluated, and physiological parameters were measured again. After the biopsy, the level of pain was evaluated using the visual analog scale (VAS), and patient satisfaction was assessed with the satisfaction scale. Fifty-two in the video-informed group and 50 in the verbally informed group completed the study. Compared to the baseline values, the STAI and STAI-state scores, systolic blood pressure, heart rate and respiratory rate of the patients in the video-informed group decreased (p < 0.0001, p < 0.0001, p = 0.003, p = 0.007, and p < 0.0001, respectively), and the systolic blood pressure, diastolic blood pressure, heart rate and respiratory rate values decreased in the verbally informed group (p < 0.0001, p = 0.014, p = 0.005, and p < 0.0001, respectively). According to VAS, 98.1% of the patients in the video-informed group and 86% of those in the verbally informed group described no or mild pain, and pain levels were lower in the video-informed group (p = 0.030). Video-based information prior to skin biopsy may be more useful in managing anxiety and pain in patients than traditional verbal information.


  • Pagetoid dyskeratosis with a palmar localization: Rapid resolution following biopsy

    by Tuğba Falay Gür, Sevil Savaş Erdoğan, Ayşe Gökçen Sade

    Background Pagetoid dyskeratosis, which is found in more than 2% of skin biopsy specimens, is accepted as a histopathological finding reflecting the abnormal keratinization process. However, to date, only a limited number of cases have been described to have brown pigmentation on the hands, triggered by friction, and present with pagetoid dyskeratosis as the only sign on histopathology and a parallel ridge pattern on dermoscopy. Aims To present and discuss the typical clinical, histopathological and dermoscopic features of pagetoid dyskeratosis, as well as to draw attention to the spontaneous resolution following biopsy. Patient We present a case of pagetoid dyskeratosis with a palmar localization, which rapidly resolved following biopsy, in a patient with no history of friction. Results PD is the only important histopathological finding in typical irregular pigmented lesions located in the hand. PD should also be considered in the differential diagnosis of lesions that show parallel ridge pattern on the hand. Two weeks after the biopsy, disappearance of the lesion may be due to the effect of inflammatory response revealed by biopsy. Conclusions Although the cause of this condition is not yet fully understood, most cases being associated with friction or rapid spontaneous resolution following biopsy, as in the current case, may indicate the reactive nature of the lesion. Further researches are required to be clarify etiology of PD.


  • Investigation of the prevalence of hand eczema among healthcare professionals in Turkey: A cross‐sectional study

    by Tuğba Falay Gür, Sevil Savaş Erdogan, Bilal Doğan

    Background Hand eczema is one of the common occupational dermatoses, having high prevalence among healthcare professionals (HCP). We found no epidemiological data in the literature concerning the prevalence of hand eczema among HCP in Turkey. Aims The aim of the present study was to investigate the prevalence of hand eczema among HCP in Turkey, determine the demographic characteristics and risk factors that cause eczema. Methods A clinical assessment- and questionnaire-based cross-sectional study was conducted with 734 HCP working in a tertiary hospital. Demographic characteristics and personal and occupational risk factors were evaluated in terms of the development of hand eczema. Results The survey response rate was 81.8%. The point prevalence of eczema was 27.6%, and the 12-month prevalence was 45.9%. Age, occupation, duration of work, atopic diseases, handwashing frequency, dry skin, moisturizing frequency, and presence and duration of glove use were important factors in the development of hand eczema. Powdered glove reaction was significantly higher in those with hand eczema (p=0.0001). Conclusions The prevalence of hand eczema is high among HCP in Turkey. Combining self-reported questionnaires with clinical examination findings can provide a more accurate calculation of the prevalence of hand eczema. The availability of epidemiological data on hand eczema can provide guidelines for the prevention and treatment of this condition. Except for situations requiring absolute handwashing, disinfecting hands with alcohol-based lotions and applying a powder-free policy in all healthcare centers will reduce the prevalence of hand eczema among HCP.


  • Hemolytic Anemia: A Rare Side Effect Related with IVIG Therapy in Stevens-Johnson Syndrome

    by Cüneyt Kara, Sevim Baysak, Zuhal Erçin, Tuğba Falay Gür, Sevil Savaş Erdoğan, Bilal Doğan

  • Subcutaneous emphysema after intralesional cryotherapy: An unusual complication

    by Tuğba Falay Gür, Sevil Savaş Erdoğan, Cüneyt Kara, Sümeyre Seda Ertekin

    Background: Intralesional cryotherapy (ILC) is a safe and well tolerated by the patient. Subcutaneous emphysema (SE) cases after spray and contact cryotherapy have been described; however, this complication has not been previously reported after ILC.Aim: Our aim is to discuss the possible causes of SE development after ILC.Method: We present a young patient that developed SE after ILC applying by insertion of an open‐ended needle to the tip of the cryotherapy gun.Results: The development of SE following ILC may have been caused by inward clefting from the ear hole, the usage of an open‐ended needle and a lack of safety system.Conclusion: It will be safer to apply special methods involving the usage of sealed distal type to prevent SE development.


  • Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross‐sectional controlled study

    by Sevil Savaş Erdoğan, Tuğba Falay Gür, Bilal Doğan

    Background: Alopecia areata (AA) and vitiligo are associated with various psychiatric comorbidities, and the care of a child with AA or vitiligo may be associated with higher anxiety and depression than healthy children.Aims: We aimed to identify psychiatric findings in children and adolescent groups with AA and vitiligo and to evaluate the levels of anxiety and depression in their parents.Methods: This study included 31 patients with AA and 29 patients with vitiligo, aged seven to 17 years, and their parents. Age‐ and gender‐matched 30 controls and their parents were included. The patients and controls completed the Revised Child Anxiety and Depression Scales‐Child version (RCADS‑C), and their parents completed the parent version (RCADS‐P). The parents also completed the Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI). In addition, the stressful event history of all cases was noted.Results: Stressful event history was higher in the vitiligo group compared to the AA group, and it was higher in the AA and vitiligo groups compared to the control group. Separation anxiety, generalized anxiety, social phobia, and major depressive disorder (MDD) scores were higher in the AA group than controls according to the RCADS‐C. According to the RCADS‐P, panic disorder (PD), MDD, and total anxiety scores were higher in the AA group. Only the PD and MDD scores were higher in the vitiligo group than those of the controls based on the RCADS‐P. Lastly, no significant difference was observed between the three groups concerning the parents' BAI and BDI scores.Conclusions: Stressful events were more common in pediatric patients with vitiligo than those with AA. Anxiety symptoms were more prevalent in patients with AA than those with vitiligo.


  • Effect of omalizumab use on glucose homeostasis in non-diabetic patients with chronic urticaria

    by Tugba Falay Gur, Sevil Savas Erdogan, Vefa Aslı Erdemir, Bilal Doğan

    Purpose: In some diabetic patients receiving omalizumab therapy, blood glucose regulation is impaired. However, the effect of omalizumab on glucose homeostasis in non-diabetic patients remains unknown. Methods: The patients were given subcutaneous omalizumab at a dose of 300 mg every four weeks for the treatment of chronic urticaria in the present study. Fasting blood glucose, fasting plasma insulin, total cholesterol, triglyceride, high-density (HDL) and low-density lipoprotein (LDL) were studied before and at the 12th week of treatment. The homeostatic model assessment for insulin resistance (HOMA-IR) was used to determine insulin resistance. Results: Forty of the 45 patients included in the study completed 12 weeks of treatment. While fasting blood glucoses (p = 0.011) and HOMA-IR values (p = 0.027) were significantly increased in the 12th week, the increase in fasting insulin level was not significant (p = 0.07). After treatment, 10 patients developed impaired fasting glucose and 13 developed insulin resistance. Conclusion: The increase in blood glucose levels may be associated with the paradoxically increase of histamine levels in the blood by omalizumab. If this increase cannot be balanced with insulin, patients may develop impaired glucose tolerance and insulin resistance. Therefore, we suggest that patients using omalizumab should be followed up for glucose homeostasis and insulin resistance.